Find DL-Tartaric acid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2,3-dihydroxysuccinic acid, Dl-tartaric acid, 2,3-dihydroxybutanedioic acid, 526-83-0, 133-37-9, Racemic acid
Molecular Formula
C4H6O6
Molecular Weight
150.09  g/mol
InChI Key
FEWJPZIEWOKRBE-UHFFFAOYSA-N

DL-Tartaric acid
Tartaric Acid is a white crystalline dicarboxylic acid found in many plants, particularly tamarinds and grapes. Tartaric acid is used to generate carbon dioxide through interaction with sodium bicarbonate following oral administration. Carbon dioxide extends the stomach and provides a negative contrast medium during double contrast radiography. In high doses, this agent acts as a muscle toxin by inhibiting the production of malic acid, which could cause paralysis and maybe death.
1 2D Structure

DL-Tartaric acid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,3-dihydroxybutanedioic acid
2.1.2 InChI
InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)
2.1.3 InChI Key
FEWJPZIEWOKRBE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(C(C(=O)O)O)(C(=O)O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. (r*,r*)-(+-)-2,3-dihydroxybutanedioic Acid, Monoammonium Monosodium Salt

2. Aluminum Tartrate

3. Ammonium Tartrate

4. Calcium Tartrate

5. Calcium Tartrate Tetrahydrate

6. Mn(iii) Tartrate

7. Potassium Tartrate

8. Seignette Salt

9. Sodium Ammonium Tartrate

10. Sodium Potassium Tartrate

11. Sodium Tartrate

12. Stannous Tartrate

13. Tartaric Acid, ((r*,r*)-(+-))-isomer

14. Tartaric Acid, (r*,s*)-isomer

15. Tartaric Acid, (r-(r*,r*))-isomer

16. Tartaric Acid, (s-(r*,r*))-isomer

17. Tartaric Acid, Ammonium Sodium Salt, (1:1:1) Salt, (r*,r*)-(+-)-isomer

18. Tartaric Acid, Calcium Salt, (r-r*,r*)-isomer

19. Tartaric Acid, Monoammonium Salt, (r-(r*,r*))-isomer

20. Tartrate

2.2.2 Depositor-Supplied Synonyms

1. 2,3-dihydroxysuccinic Acid

2. Dl-tartaric Acid

3. 2,3-dihydroxybutanedioic Acid

4. 526-83-0

5. 133-37-9

6. Racemic Acid

7. Traubensaure

8. Racemic Tartaric Acid

9. Dl-tartrate

10. Paratartaric Acid

11. Paratartaric Aicd

12. Uvic Acid

13. Acidum Tartaricum

14. Butanedioic Acid, 2,3-dihydroxy-

15. Resolvable Tartaric Acid

16. Nsc62778

17. Tartaric Acid D,l

18. E-7050 (2s,3s)-2,3-dihydroxysuccinic Acid

19. Tartaric Acid, L-(+)-

20. 2,3-dihydroxy-succinic Acid

21. Baros

22. Chebi:15674

23. Dl-2,3-dihydroxybutanedioic Acid

24. (2rs,3rs)-tartaric Acid

25. Tartrate

26. 1007601-97-9

27. Nsc 148314

28. Butanedioic Acid, 2,3-dihydroxy-, (2r,3r)-rel-

29. Butanedioic Acid, 2,3-dihydroxy-(r*,r*)-(.+/-.)-

30. Butanedioic Acid, 2,3-dihydroxy-, (r*,r*)-

31. 868-14-4

32. (.+-.)-tartaric Acid

33. (2r,3r)-2,3-dihydroxybernsteinsaeure

34. Tartaric Acid (van)

35. Kyselina Vinna [czech]

36. Nsc155080

37. Tartaric Acid [usan:jan]

38. D-alpha,beta-dihydroxysuccinic Acid

39. Nsc-148314

40. Kyselina 2,3-dihydroxybutandiova [czech]

41. (+) Tartaric Acid

42. (-) Tartaric Acid

43. 1,2-dihydroxyethane-1,2-dicarboxylic Acid

44. Ai3-06298

45. 1,2-dicarboxylic Acid

46. Wln: Qvyqyqvq

47. (-) D-tartaric Acid

48. Sal Tartar (salt/mix)

49. Tartaric Acid, (dl)-

50. Butanedioic Acid, 2,3-dihydroxy- (r-(r*,r*))-

51. Butanedioic Acid, 2,3-dihydroxy-, [s-(r*,r*)]-

52. Malic Acid, 3-hydroxy-

53. Laevo-(+)-tartaric Acid

54. 2,3-dihydroxysuccinicacid

55. Dextro,laevo-tartaric Acid

56. Succinic Acid,3-dihydroxy

57. Schembl848

58. Bmse000167

59. Succinic Acid,3-dihydroxy-

60. (.+/-.)-tartaric Acid

61. Dsstox_cid_26986

62. Dsstox_rid_82036

63. Dsstox_gsid_46986

64. Oprea1_827092

65. Tartaric Acid, (l)

66. Tartaric Acid, (.+-.)-

67. Butanedioic Acid,3-dihydroxy-

68. Chembl333714

69. Dihydroxysuccinic Acid, (dl)-

70. Tartaric Acid, (.+/-.)-

71. L+tartaric Acid Fcc, Nf, Usp

72. Dtxsid501031477

73. Hms3370m15

74. (+)-2,3-dihydroxybutanedioic Acid

75. Bcp14303

76. Tox21_302052

77. Bbl011588

78. Mfcd00064206

79. Nsc133735

80. Nsc148314

81. Nsc608773

82. S2997

83. Stk387106

84. 2,3-dihydroxysuccinic Acid, (dl)-

85. 3-carboxy-2,3-dihydroxypropanoic Acid

86. Akos000120086

87. Akos016844048

88. Nsc-133735

89. Nsc-608773

90. Sb44180

91. Sb44181

92. Smp2_000051

93. D-.alpha.,.beta.-dihydroxysuccinic Acid

94. Ncgc00256063-01

95. Ncgc00347131-03

96. As-10983

97. Cas-133-37-9

98. Nci60_001102

99. (+)-2,3-dihydroxy-1,4-butanedioic Acid

100. Db-016129

101. Db-016159

102. Db-042899

103. Am20110247

104. Cs-0022654

105. Ft-0624346

106. Ft-0625514

107. Ft-0628018

108. Ft-0628243

109. Ft-0656080

110. Ft-0772946

111. Ft-0773804

112. T0001

113. (+/-)-2,3-dihydroxy-1,4-butanedioic Acid

114. A22866

115. Butanedioic Acid,3-dihydroxy- [r-(r*,r*)]-

116. 133d379

117. A829202

118. Q194322

119. Butanedioic Acid,3-dihydroxy-, (r*,r*)-(.+-.)-

120. F2191-0230

121. Z1258943354

122. 1,2-dihydroxyethane-1,2-dicarboxylic Acid;2,3-dihydrosuccinic Acid

123. (2s,3s)-(-)-tartaric Acid; D(-)-threaric Acid;d(-)-dihydroxysuccinic Acid

124. Copper, Mixt. With [r-(r*,r*)]-2,3-dihydroxybutanedioic Acid Monopotassium Salt

2.3 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 150.09 g/mol
Molecular Formula C4H6O6
XLogP3-1.9
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass150.01643791 g/mol
Monoisotopic Mass150.01643791 g/mol
Topological Polar Surface Area115 Ų
Heavy Atom Count10
Formal Charge0
Complexity134
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Stress incontinence, female


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 133-37-9 / DL-Tartaric acid API manufacturers, exporters & distributors?

DL-Tartaric acid manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of DL-Tartaric acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right DL-Tartaric acid manufacturer or DL-Tartaric acid supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred DL-Tartaric acid manufacturer or DL-Tartaric acid supplier.

PharmaCompass also assists you with knowing the DL-Tartaric acid API Price utilized in the formulation of products. DL-Tartaric acid API Price is not always fixed or binding as the DL-Tartaric acid Price is obtained through a variety of data sources. The DL-Tartaric acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

DL-Tartaric acid

Synonyms

2,3-dihydroxysuccinic acid, 2,3-dihydroxybutanedioic acid, 526-83-0, 133-37-9, Racemic acid, Traubensaure

Cas Number

133-37-9

About DL-Tartaric acid

Tartaric Acid is a white crystalline dicarboxylic acid found in many plants, particularly tamarinds and grapes. Tartaric acid is used to generate carbon dioxide through interaction with sodium bicarbonate following oral administration. Carbon dioxide extends the stomach and provides a negative contrast medium during double contrast radiography. In high doses, this agent acts as a muscle toxin by inhibiting the production of malic acid, which could cause paralysis and maybe death.

DL-Tartaric acid Manufacturers

A DL-Tartaric acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DL-Tartaric acid, including repackagers and relabelers. The FDA regulates DL-Tartaric acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DL-Tartaric acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of DL-Tartaric acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

DL-Tartaric acid Suppliers

A DL-Tartaric acid supplier is an individual or a company that provides DL-Tartaric acid active pharmaceutical ingredient (API) or DL-Tartaric acid finished formulations upon request. The DL-Tartaric acid suppliers may include DL-Tartaric acid API manufacturers, exporters, distributors and traders.

click here to find a list of DL-Tartaric acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

DL-Tartaric acid JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The DL-Tartaric acid Drug Master File in Japan (DL-Tartaric acid JDMF) empowers DL-Tartaric acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the DL-Tartaric acid JDMF during the approval evaluation for pharmaceutical products. At the time of DL-Tartaric acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of DL-Tartaric acid suppliers with JDMF on PharmaCompass.

DL-Tartaric acid GMP

DL-Tartaric acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of DL-Tartaric acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DL-Tartaric acid GMP manufacturer or DL-Tartaric acid GMP API supplier for your needs.

DL-Tartaric acid CoA

A DL-Tartaric acid CoA (Certificate of Analysis) is a formal document that attests to DL-Tartaric acid's compliance with DL-Tartaric acid specifications and serves as a tool for batch-level quality control.

DL-Tartaric acid CoA mostly includes findings from lab analyses of a specific batch. For each DL-Tartaric acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

DL-Tartaric acid may be tested according to a variety of international standards, such as European Pharmacopoeia (DL-Tartaric acid EP), DL-Tartaric acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DL-Tartaric acid USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty